Download presentation
Presentation is loading. Please wait.
Published byCordelia Heath Modified over 6 years ago
1
Evaluation of California’s Hub and Spoke System
Darren Urada, Ph.D. and Howard Padwa, Ph.D. UCLA Integrated Substance Abuse Programs July 25, 2016 CA Hub & Spoke System Steering Committee Sacramento, CA
2
Building a plane while flying
3
Reasons for Evaluation
“. . . while I am releasing the funding for the first year immediately, my intention for the second year is to develop funding allocations and policies that are the most clinically sound, effective and efficient to identify best practices, lessons learned, and key strategies that produce measureable results.” Tom Price US Health and Human Services Secretary April
4
Reasons for Evaluation
“. . . while I am releasing the funding for the first year immediately, my intention for the second year is to develop funding allocations and policies that are the most clinically sound, effective and efficient to identify best practices, lessons learned, and key strategies that produce measureable results.” Tom Price US Health and Human Services Secretary April
5
Evaluation Goals Document
Best practices Lessons learned Measurable results. Provide feedback for Learning Collaborative / Training.
6
Where data already exists, use it.
Data Sources Where data already exists, use it. California Opioid Dashboard (CDPH, OSHPD, DOJ, CHCF) Data quality – confirm with grantees that they are reporting to these
8
Where data already exists, use it.
Data Sources Where data already exists, use it. California Opioid Dashboard (CDPH, OSHPD, DOJ) Additional analyses on underlying data where necessary CalOMS-Tx Drug Medi-Cal, Medi-Cal Managed Care, Pharmacy Claims New data collection Interviews Provider Surveys Patient Surveys/Interviews Data quality – confirm with grantees that they are reporting to these
9
Evaluation Structure The RE-AIM Implementation Framework
REACH: How well does H&SS reach patients? EFFECTIVENESS: How effective is H&SS at improving patient and population health outcomes? ADOPTION: To what extent are programs participating in H&SS? IMPLEMENTATION: To what extent/how are programs implementing H&SS? MAINTENANCE: To what extent are H&SS policies and procedures being maintained?
10
Reach Number of patients who receive OUD treatment
Number of patients who receive bup, methadone, naltrexone Number of patients who receive OUD recovery services Access to MAT services in counties with the highest OD rates Access to integrated MAT services in urban areas Access to NTP and/or medication units in underserved areas MAT access for tribes
11
Effectiveness Number of patients on MAT for six months or more (engagement measure) Number of patients on MAT for two years or more (retention measure) Numbers and rates of opioid use Numbers and rates of opioid-overdose related deaths Opioid-related ED visits and hospitalizations Patient perceptions
12
Adoption, Implementation, Maintenance
Number of providers delivering MAT Number of OUD prevention and treatment providers Number of buprenorphine waivered physicians/NPs Number of opioid users treated per waivered physician/NP Availability of buprenorphine counseling for patients Support services for primary care prescribers Implementation Types of models and systems that develop Barriers and facilitators Maintenance over time Potential analyses of costs. Still in development.
13
Patient Surveys & Interviews
Contact information needed Phone number, , address. - What is already in your EHR? Permission to contact them needed. Data transmission plans still being worked out. UCLA will: contact them shortly after they have been seen, pay them. follow-up weeks or months later (time period TBD). ask about patient perceptions, outcomes Only a sample of patients, e.g. first X number of patients at the beginning of each month. What would be practical?
15
Questions? Comments? Darren Urada, Ph.D.
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.